Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer - PubMed

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer - PubMed

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer

Justin Mills 1, Adeola Fakolade 2

Affiliations 

• PMID: 32053324

Similar articles

• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement

  VA Moyer et al. Ann Intern Med 160 (4), 271-81. 2014. PMID 24366376.

  The USPSTF recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools …
• Psychosocial Predictors of BRCA Counseling and Testing Decisions Among Urban African-American Women

  HS Thompson et al. Cancer Epidemiol Biomarkers Prev 11 (12), 1579-85. Dec 2002. PMID 12496047.

  Genetic counseling and testing for mutations in XXX (BRCA)1/2 genes that increase breast cancer susceptibility potentially offer a number of benefits (e.g., more informed …
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement

  US Preventive Services Task Force et al. JAMA 322 (7), 652-665. 2019. PMID 31429903.

  The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry …
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

  HD Nelson et al. Ann Intern Med 160 (4), 255-66. 2014. PMID 24366442. - Review

  Studies of risk assessment, genetic counseling, genetic testing, and interventions to reduce cancer and mortality indicate potential benefits and harms that vary accordin …
• Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [Internet]

  HD Nelson et al. Sep 2005. PMID 20722133. - Review

  The evidence base for genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility as a screening strategy is limited by lack of …